# myEDmeds

We're a nationwide low-cost platform for online Erectile Dysfunction medication.

## Elevator pitch
We are a LegitScript certified, online platform providing access to Erectile Dysfunction medications without leaving your home or office.

- Canonical URL: https://wefunder.com/myedmeds
- Entity ID: wefunder:company:93303
- Last updated: 2026-07-08T05:01:49Z
- Generated at: 2026-07-08T15:19:05Z

## Quick facts
- Doctors and pharmacy fulfillment partner licensed and certified in all 50 states and D.C.
- Long-term deal with industry-leading fulfillment partner ensuring reliable and scalable distribution.
- $540K prior investor base includes several prominent, experienced business leaders.
- Huge opportunity in the growing $3.8 billion dollar Erectile Dysfunction medication market.
- Founded, owned and led by pharmacy professionals with more than 60 years combined experience.
- Poised to capitalize on the explosive growth of telemedicine by becoming a full telehealth platform.
- Investors that are also ED medication users won't pay more than $1 per pill for ED meds.
- Ambassador/affiliate program to potentially yield investment income during growth phase of company.

## Active fundraises
- wefunder:fundraise:48945: 4(a)(6) successful (USD)
- wefunder:fundraise:49140: 4(a)(6) successful (USD)

## FAQ
1. **Hi, do you all plan on remaining an LLC for tax purposes, and do you anticipate becoming profitable within the near future?**
   - Hello Lucas and thanks for inquiring. We do anticipate converting to a Corporation within the next 12-15 months and prior to the SAFE converting to equity. In terms of profitability, perhaps it is important to note that we are hoping to attract investors who also happen to use either sildenafil or tadalafil. Part of our marketing message is "why buy from anyone else if you can buy from yourself.....and cheaper"! If we are successful in this messaging, and considering our incredibly low fixed ...
2. **How is this better than companies that have already been doing this for over 10 years for a valuation of 30M? How would you beat out your competitors since anyone can really do this**
   - Thanks for you inquiry Patrick. I think it's important to understand that a HIPAA compliant telehealth site is not like a typical retail site, perhaps for golf balls, that you might find online. The complexity of coordinating a licensed provider network for the purposes of getting a legal prescription and then establishing a nationwide distribution network for those prescriptions is a huge multi-year undertaking. One of the advantages that we have over those competitors who have been in the g...
3. **How do you compete with everyone who has medical insurance. If I wanted ED meds it would cost me $5.00.**
   - Good afternoon Mr Gessner and thank you for your inquiry. If you are one of the few, and I do mean few, fortunate people to have coverage for "lifestyle" meds within your health plan, simply put, we can't. My experience however, after 12 years in the health insurance business and decades in retail pharmacy, is that the overwhelming majority of health plans DO NOT COVER meds such as Sildenafil and Tadalafil. Most beneficiaries don't realize that until the pay a physician office visit copay and...
4. **What is the end state or exit? Acquisition? Pay dividends?**
   - Good afternoon Craig and thanks for your inquiry. At this point I would say that the most likely exit scenario is an acquisition. We believe that once the proverbial "big boys" (Roman, HIMS, RexMD, etc) realize that we can do exactly what they do at a much lower price point, at least in terms of ED medication, they may want to eliminate a low-cost producer. We already have integrated nationwide prescription distribution capability with scalability that HIMS is trying to build out as I type......
5. **Really interesting presentation ... I have invested but I am a supply chain consutlant and you will need me to help with order management, warehousing and distribution as you scale!**
   - Good afternoon Antony and thank you for placing your trust in our team to work for you as an investor! I'm not sure how much insight into our prescription distribution channel you were able to extract from our video, but that is actually one of our greatest competitive strengths as we start to grow. Our fulfillment partner and its affiliated companies currently fill over 16 million prescriptions annually, and most of those are out of their existing 250,000+s.f. facility in Pennsylvania. Shoul...

## Team
- Louis Scerbo (Co-Founder & CEO)
- Ryan Lombardi (Co-Founder & CXO)
- Dr. Rich Maenza (Medical Advisor/Consultant)
- James Hopkins III (Co-lead software developer)
- Chris Daubert (Co-lead software developer)
- Mark Zilner (COO InnovaScript Pharmacy Fulfillment )

## Recent posts
- Onward & UPWARD........with better VISION too ! (2022-03-02T18:44:14Z)
- FORM C Filing (2021-12-02T21:47:05Z)

## Q&A
- Q: Could we please have an update?
- Q: What is the end state or exit? Acquisition? Pay dividends?
  - A: Good afternoon Craig and thanks for your inquiry. At this point I would say that the most likely exit scenario is an acquisition. We believe that once the proverbial "big boys" (Roman, HIMS, RexMD, etc) realize that we can do exactly what they do at a much lower price point, at least in terms of ED medication, they may want to eliminate a low-cost producer. We already have integrated nationwide prescription distribution capability with scalability that HIMS is trying to build out as I type......and they carry a $900M+ market cap as of today. Please feel free to reach me for further discussion via lou@myedmeds.com where.....TOGETHER WE RISE!
- Q: as an investor/physician (who has worked with HIMS for 4 years) - how do i get started with my local patient base and making recommendations and benefiting from the partnership details? what is the process of recruiting physicians to be part of the medical team prescribing the treatments? i am licensed in CA, NV, NM, AZ, ID, UT, CO, Tx and Montana....which has been useful for HIMS
- Q: I was very interested in investing but have some concerns after watching how the crowdfunding raise has done thus far after a few months. Your revenue for the business is telling me that something is wrong with how you are actively acquiring new customers in order to increase your MRR. Increasing the monthly recurring revenue will help you become profitable and scale the business. What is your game plan from a marketing perspective to help you acquire those new customers and increase your MRR (month after month, and year after year)?
- Q: Really interesting presentation ... I have invested but I am a supply chain consutlant and you will need me to help with order management, warehousing and distribution as you scale!
  - A: Good afternoon Antony and thank you for placing your trust in our team to work for you as an investor! I'm not sure how much insight into our prescription distribution channel you were able to extract from our video, but that is actually one of our greatest competitive strengths as we start to grow. Our fulfillment partner and its affiliated companies currently fill over 16 million prescriptions annually, and most of those are out of their existing 250,000+s.f. facility in Pennsylvania. Should we (dare I say, "WHEN WE"!) reach the point where further automation is necessary, their prescription processing system can scale to several times their current prescription volume with minimal capital investment. Please feel free to reach me directly for further discussion via email to lou@myedmeds.com where........TOGETHER WE RISE!
- Q: How do you compete with everyone who has medical insurance. If I wanted ED meds it would cost me $5.00.
  - A: Good afternoon Mr Gessner and thank you for your inquiry. If you are one of the few, and I do mean few, fortunate people to have coverage for "lifestyle" meds within your health plan, simply put, we can't. My experience however, after 12 years in the health insurance business and decades in retail pharmacy, is that the overwhelming majority of health plans DO NOT COVER meds such as Sildenafil and Tadalafil. Most beneficiaries don't realize that until the pay a physician office visit copay and then go to their pharmacy only to find out that the meds aren't covered, or are only covered for a fixed number of tablets per month. Do you really want your insurance company dictating your sexual habits? If you have further questions, please feel free to reach out to me at lou@myedmeds.com.
- Q: How is this better than companies that have already been doing this for over 10 years for a valuation of 30M? How would you beat out your competitors since anyone can really do this
  - A: Thanks for you inquiry Patrick. I think it's important to understand that a HIPAA compliant telehealth site is not like a typical retail site, perhaps for golf balls, that you might find online. The complexity of coordinating a licensed provider network for the purposes of getting a legal prescription and then establishing a nationwide distribution network for those prescriptions is a huge multi-year undertaking. One of the advantages that we have over those competitors who have been in the generic ED business since Viagra lost patent protection in 2019 is that our pharmacy fulfillment partner already fills 16 million prescriptions a year on a nationwide basis and has positioned us to be one of the lowest cost providers in the online ED space. Please feel free to reach out to me at lou@myedmeds.com if you would like to discuss this further. Thanks again for your interest in our company Patrick.
- Q: Hi, do you all plan on remaining an LLC for tax purposes, and do you anticipate becoming profitable within the near future?
  - A: Hello Lucas and thanks for inquiring. We do anticipate converting to a Corporation within the next 12-15 months and prior to the SAFE converting to equity. In terms of profitability, perhaps it is important to note that we are hoping to attract investors who also happen to use either sildenafil or tadalafil. Part of our marketing message is "why buy from anyone else if you can buy from yourself.....and cheaper"! If we are successful in this messaging, and considering our incredibly low fixed costs, we are hopeful that we can break even by the end of 2022. Given our pricing compared to others in our niche and the prevalence of ED in the U.S. (about 30 million men/$3B+ market) we are positioned well to take a significant portion of that market. I can be reached at lou@myedmeds.com for further discussion. Thanks again Lucas.